You are here:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. Future IFFIm proceeds from new pledges made at the Berlin pledging conference are indicative and are based on certain assumptions including future interest rates and foreign exchange rates generated from financial market data, and donor payment schedules. These assumptions may differ from conditions prevailing at the time of grant and legal agreement signing, which may result in different projected and realised IFFIm proceeds.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Notes:Direct Contributions (including Matching Fund)Received contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014, 2015 and 2016, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for years 2017 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 December 2016 or using the rates applicable to any hedge agreement in place.
IFFIm contributionsReceived contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions are expressed in US$ equivalents as follows:
The United States is one of the Vaccine Alliance’s original six donor countries and contributes to Gavi through direct contributions. The United States has placed a significant emphasis on ending preventable child deaths through reducing child mortality and targeting funding for high-impact, low-cost interventions. Vaccines and immunizations are an important component of this initiative and Gavi is a key partner in helping the United States achieve its goals. Moreover, the United States continues to be an important partner to Gavi by aligning programmatic interests in country to ensure greater efficiency and impact on the ground.
Annual contributions have increased from USD 48 million in 2001 to USD 200 million in 2015. At Gavi’s first pledging conference in June 2011, the United States pledged USD 450 million for the period 2012-2014, subject to congressional approval. In addition to this pledge announcement, the US contributed USD 90 million for 2011. At the Gavi pledging conference in January 2015, the United States pledged USD 1 billion for the period 2015-2018, subject to congressional approval, which includes the 2016 contribution of USD 235 million. The 2016 funding level represents the largest annual contribution to the Vaccine Alliance from the United States to date.
Contributions and pledges in total:
Gavi Pledging Conference - Berlin, 26-27 January 2015
Dr Raj Shah, Administrator, USAID, addressing the conference
United States pledge announcement
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here